[1]
G. C. Matos de Oliveira, G. Magno Baptista, E. Izidorio Lima, A. M. Vinahes Bittencourt, e L. J. de Oliveira Andrade, “Examination of the scientific evidences for off-label use of medications in non-alcoholic fatty liver disease”, cmbio, vol. 18, nº 2, p. 161–174, nov. 2019.